Prevalence of Potentially Severe Drug-Drug Interactions in Ambulatory Patients with Dyslipidaemia Receiving HMG-CoA Reductase Inhibitor Therapy

Alexandra E. Rtz Bravo, Lydia Tchambaz, Anita Kr henb hl-Melcher, Lorenzo Hess, Raymond G. Schlienger, Stephan Kr henb hl

Drug Safety · 2005 · 79 citations · 42 references

Concepts

References

42